Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial

BACKGROUND: SSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India, but there are no published data from trials o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS Negl Trop Dis
Main Authors: Wasunna, Monique, Njenga, Simon, Balasegaram, Manica, Alexander, Neal, Omollo, Raymond, Edwards, Tansy, Dorlo, Thomas P. C., Musa, Brima, Ali, Mohammed Hassan Sharaf, Elamin, Mohammed Yasein, Kirigi, George, Juma, Rashid, Kip, Anke E., Schoone, Gerard J., Hailu, Asrat, Olobo, Joseph, Ellis, Sally, Kimutai, Robert, Wells, Susan, Khalil, Eltahir Awad Gasim, Strub Wourgaft, Nathalie, Alves, Fabiana, Musa, Ahmed
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5023160/
https://ncbi.nlm.nih.gov/pubmed/27627654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0004880
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados